Patient-level costs of central line-associated bloodstream infections caused by multidrug-resistant microorganisms in a public intensive care unit in Brazil: a retrospective cohort study

Rev Bras Ter Intensiva. 2023 Mar 3;34(4):529-533. doi: 10.5935/0103-507X.20220313-pt. eCollection 2023.

[Article in English, Portuguese]

Authors

Antonio Paulo Nassar Júnior¹, Isabella Lott Bezerra¹, Daniel Tavares Malheiro¹, Maria Dolores Montoya Diaz², Guilherme Paula Pinto Schettino³, Adriano José Pereira¹

Affiliations

¹ IMPACTO-MR Program, Health Economics, Hospital Israelita Albert Einstein - São Paulo (SP), Brasil.
² Departamento de Economia, Faculdade de Economia, Administração, Contabilidade e Atuária, Universidade de São Paulo - São Paulo (SP), Brasil.
³ Instituto de Responsabilidade Social, Hospital Israelita Albert Einstein - São Paulo (SP), Brasil.

No abstract available

Publication types

Letter

MeSH terms

Bacteremia* / drug therapy
Bacteremia* / epidemiology
Brazil
Catheter-Related Infections*
Cross Infection* / epidemiology
Humans
Intensive Care Units
Retrospective Studies
Sepsis*